- Stocks
- Pharma & Healthcare
- Apollo Hospitals Enterprise
Apollo Hospitals Enterprise share price
NSE: APOLLOHOSPPharma & HealthcareMedical Care Facilities
Apollo Hospitals Enterprise at a glance
Apollo Hospitals Enterprise (NSE: APOLLOHOSP) closed at ₹7,626.00 on 22 Oct 2026. With a market capitalisation of ₹1,22,065 Cr, it ranks 79th by market cap among the 3,928 NSE companies Pivot tracks (a large-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Care Facilities.
Its return on equity was 20.5% in FY26. Its 52-week range is ₹6,696.50 (23 Jan 2026) to ₹9,070.50 (23 Sep 2026); the last close is 15.9% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹6,606 Cr (+18.1% year on year) and net profit ₹541 Cr (+34.0%), on a consolidated basis. Promoters held 28.02% of the company as of 30 Jun 2026; 2.49% of promoter shares were pledged.
Key numbers
- Market cap
- ₹1,22,065 CrRank 79 on NSE
- Price to book
- 11.27×FY26
- EPS (TTM)
- ₹135.05to Q4 FY26
- ROE
- 20.5%FY26
- ROCE
- 19.6%FY26
- Debt to equity
- 0.6FY26
- Net profit margin
- 7.8%FY26
- Book value / share
- ₹659.26FY26
- 52-week high
- ₹9,070.5023 Sep 2026
- 52-week low
- ₹6,696.5023 Jan 2026
Returns to —
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Apollo Hospitals Enterprise quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹5,086 Cr | ₹5,589 Cr | ₹5,527 Cr | ₹5,592 Cr | ₹5,842 Cr | ₹6,304 Cr | ₹6,477 Cr | ₹6,606 Cr |
| Revenue YoY | +15.1% | +15.3% | +13.9% | +13.1% | +14.9% | +12.8% | +17.2% | +18.1% |
| Net profit | ₹304 Cr | ₹390 Cr | ₹374 Cr | ₹404 Cr | ₹427 Cr | ₹488 Cr | ₹501 Cr | ₹541 Cr |
| Net profit YoY | +81.5% | +58.1% | +47.9% | +61.7% | +40.6% | +25.1% | +34.0% | +34.0% |
| Net margin | 6.0% | 7.0% | 6.8% | 7.2% | 7.3% | 7.7% | 7.7% | 8.2% |
| EPS | ₹21.23 | ₹26.34 | ₹25.89 | ₹27.10 | ₹30.10 | ₹33.19 | ₹34.94 | ₹36.82 |
Apollo Hospitals Enterprise financials
| Item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Revenue | ₹10,560 Cr | ₹14,663 Cr | ₹16,613 Cr | ₹19,059 Cr | ₹21,794 Cr | — |
| Operating profit | ₹160 Cr | ₹1,284 Cr | ₹1,144 Cr | ₹1,361 Cr | ₹2,006 Cr | — |
| Net profit | ₹136 Cr | ₹1,101 Cr | ₹888 Cr | ₹917 Cr | ₹1,472 Cr | — |
| EPS (₹) | ₹11.00 | ₹73.00 | ₹57.00 | ₹63.00 | ₹101.00 | — |
| Cash from operations | ₹1,273 Cr | ₹1,628 Cr | ₹1,377 Cr | ₹1,920 Cr | ₹2,136 Cr | — |
| Total debt | ₹2,473 Cr | ₹2,427 Cr | ₹1,938 Cr | ₹2,236 Cr | ₹4,417 Cr | ₹2,430 Cr |
| Shareholders' equity | ₹4,603 Cr | ₹5,623 Cr | ₹6,197 Cr | ₹6,935 Cr | ₹8,212 Cr | ₹9,480 Cr |
Apollo Hospitals Enterprise shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 29.34% | 29.34% | 28.02% | 28.02% | 28.02% | 28.02% |
| Foreign institutions | 42.74% | 43.49% | 44.20% | 43.54% | 42.62% | 41.50% |
| Domestic institutions | 22.29% | 21.34% | 21.12% | 21.51% | 22.76% | 23.72% |
| Non-institutions | 5.41% | 5.61% | 6.43% | 6.71% | 6.37% | 6.54% |
| Promoter shares pledged | 13.47% | 13.11% | 8.58% | 2.49% | 2.49% | 2.49% |
Apollo Hospitals Enterprise vs peers
The listed Pharma & Healthcare companies nearest to Apollo Hospitals Enterprise by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| TORNTPHARMTorrent Pharmaceuticals | — | — | — | ₹1,49,924 Cr | — | — |
| APOLLOHOSPApollo Hospitals Enterprise | — | — | — | ₹1,22,065 Cr | — | — |
| CIPLACipla | — | — | — | ₹1,09,204 Cr | — | — |
| ZYDUSLIFEZydus Lifesciences | — | — | — | ₹1,07,747 Cr | — | — |
| LUPINLupin | — | — | — | ₹1,07,522 Cr | — | — |
| MAXHEALTHMax Healthcare Institute | — | — | — | ₹1,06,545 Cr | — | — |
| MANKINDMankind Pharma | — | — | — | ₹99,705 Cr | — | — |
Ask anything about Apollo Hospitals Enterprise
Pivot answers on the live chart with evidence you can check, and tests strategies against APOLLOHOSP's own history. Try: “Why has APOLLOHOSP moved over the last three months?” · “Backtest a 50-day moving-average crossover on APOLLOHOSP over five years” · “Compare APOLLOHOSP with TORNTPHARM on margins and valuation”
Frequently asked questions about Apollo Hospitals Enterprise
What is the share price of Apollo Hospitals Enterprise today?
Apollo Hospitals Enterprise (NSE: APOLLOHOSP) last closed at ₹7,626.00 on 22 Oct 2026. Its 52-week high is ₹9,070.50 and its 52-week low is ₹6,696.50.
What is the market cap of Apollo Hospitals Enterprise?
Apollo Hospitals Enterprise's market capitalisation is ₹1,22,065 Cr (₹1.22 lakh Cr) at the — close, ranking 79th among the NSE companies Pivot tracks.
What is the ROE and ROCE of Apollo Hospitals Enterprise?
Return on equity was 20.5% in FY26 and return on capital employed was 19.6% in FY26 (consolidated figures).
Is Apollo Hospitals Enterprise a debt-free company?
No. Apollo Hospitals Enterprise's debt-to-equity ratio was 0.6 in FY26, with total debt of ₹5,741 Cr.
What were Apollo Hospitals Enterprise's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Apollo Hospitals Enterprise reported revenue of ₹6,606 Cr, +18.1% year on year, and net profit of ₹541 Cr, +34.0% year on year.
What is the shareholding pattern of Apollo Hospitals Enterprise?
As of 30 Jun 2026: promoters 28.02%, foreign institutions 41.50%, domestic institutions 23.72%, non-institutions 6.54%. 2.49% of promoter shares were pledged.
Who are Apollo Hospitals Enterprise's competitors?
The listed Pharma & Healthcare companies closest to Apollo Hospitals Enterprise by market cap are Torrent Pharmaceuticals, Cipla, Zydus Lifesciences, Lupin, Max Healthcare Institute and Mankind Pharma.
Is Apollo Hospitals Enterprise a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Apollo Hospitals Enterprise's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on APOLLOHOSP against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026. Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 3,928 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Pharma & Healthcare stocks · companies starting with A · all NSE stocks · this page as text